These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36186451)

  • 1. Prevalence of resistance mutations associated with integrase inhibitors in therapy-naive HIV-positive patients in Baoding, Hebei province, China.
    Fan W; Wang X; Zhang Y; Meng J; Su M; Yang X; Shi H; Shi P; Lu X
    Front Genet; 2022; 13():975397. PubMed ID: 36186451
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of integrase strand transfer inhibitor (INSTIs) resistance mutations in Henan Province, China (2018-2020).
    Yang Z; Yang X; Deng X; Wei S; Liu J; Ma J; Zhao Q; Huo Y
    Infection; 2021 Dec; 49(6):1195-1202. PubMed ID: 34279816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective resistance profiles emerging in patient-derived clinical isolates with cabotegravir, bictegravir, dolutegravir, and elvitegravir.
    Oliveira M; Ibanescu RI; Anstett K; Mésplède T; Routy JP; Robbins MA; Brenner BG;
    Retrovirology; 2018 Aug; 15(1):56. PubMed ID: 30119633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of integrase strand transfer inhibitor resistance mutations confers high-level resistance to dolutegravir in non-B subtype HIV-1 strains from patients failing raltegravir in Uganda.
    Ndashimye E; Avino M; Olabode AS; Poon AFY; Gibson RM; Li Y; Meadows A; Tan C; Reyes PS; Kityo CM; Kyeyune F; Nankya I; Quiñones-Mateu ME; Arts EJ
    J Antimicrob Chemother; 2020 Dec; 75(12):3525-3533. PubMed ID: 32853364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of HIV-1 Integrase Strand Transfer Inhibitor Resistance in Treatment-Naïve Voluntary Counselling and Testing Clients by Population Sequencing and Illumina Next-Generation Sequencing in Taiwan.
    Tsai HC; Chen IT; Tsai KW; Lee SS; Chen YS
    Infect Drug Resist; 2020; 13():4519-4529. PubMed ID: 33364799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular epidemiological characteristics of newly diagnosed HIV-1 cases in Fujian Province in 2020].
    Xie M; Lin L; Wang Z; Qiu Y; Lu X; Zhang C; Wu S
    Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi; 2023 Dec; 35(6):583-589. PubMed ID: 38413019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrase Strand Transfer Inhibitor (INSTI) Genotypic Resistance Analysis in Treatment-Naive, INSTI Free Antiretroviral-Experienced and INSTI-Experienced Turkish Patients Infected with HIV-1.
    Sayan M; Yildirim FS; Akhan S; Karaoglan I; Akalin H
    Curr HIV Res; 2022 Aug; 20(2):184-192. PubMed ID: 35240975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absence of Integrase Inhibitor-Associated Resistance Among Antiretroviral Therapy-Naïve HIV-1-Infected Adults in Guangdong Province, China, in 2018.
    Lan Y; Li L; Chen W; Deng X; Li J; Fan Q; Cai X; Cai W; Hu F
    Infect Drug Resist; 2020; 13():4389-4394. PubMed ID: 33324078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular transmission networks and pre-treatment drug resistance among individuals with acute HIV-1 infection in Baoding, China.
    Shi P; Chen Z; Meng J; Su M; Yang X; Fan W; Shi H; Gao Y; Lu X
    PLoS One; 2021; 16(12):e0260670. PubMed ID: 34855860
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of combinations of clinically observed HIV integrase mutations on phenotypic resistance to integrase strand transfer inhibitors (INSTIs): a molecular study.
    Cheung PK; Shahid A; Dong W; Lepik KJ; Montaner JSG; Brockman MA; Brumme ZL; Brumme CJ
    J Antimicrob Chemother; 2022 Mar; 77(4):979-988. PubMed ID: 35061879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of HIV-1 integrase resistance emergence and evolution in patients treated with integrase inhibitors.
    Scutari R; Alteri C; Vicenti I; Di Carlo D; Zuccaro V; Incardona F; Borghi V; Bezenchek A; Andreoni M; Antinori A; Perno CF; Cascio A; De Luca A; Zazzi M; Santoro MM;
    J Glob Antimicrob Resist; 2020 Mar; 20():163-169. PubMed ID: 31330378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemic trend, genetic characteristics, and transmission networks of HIV-1 among treatment-naive men who have sex with men in Hebei province, China.
    Lu X; Wang Y; Ma L; Liu M; Li Y; An N; Zhang X; Tang X; Li Q
    Front Microbiol; 2024; 15():1405565. PubMed ID: 39176274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility to HIV-1 integrase strand transfer inhibitors (INSTIs) in highly treatment-experienced patients who failed an INSTI-based regimen.
    Santoro MM; Fornabaio C; Malena M; Galli L; Poli A; Menozzi M; Zazzi M; White KL; Castagna A;
    Int J Antimicrob Agents; 2020 Jul; 56(1):106027. PubMed ID: 32450199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug Resistance to Integrase Strand-Transfer Inhibitors among HIV-1-Infected Adults in Guangdong, China.
    Lan Y; Li L; Xin R; Ling X; Deng X; Li J; Li L; Cai W; Li F; Hu F
    Pathogens; 2022 Nov; 11(11):. PubMed ID: 36365072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and determinants of resistance mutations in HIV-1-infected patients exposed to integrase inhibitors in a large Italian cohort.
    Modica S; Rossetti B; Lombardi F; Lagi F; Maffeo M; D'Autilia R; Pecorari M; Vicenti I; Bruzzone B; Magnani G; Paolucci S; Francisci D; Penco G; Sacchini D; Zazzi M; De Luca A; Di Biagio A
    HIV Med; 2019 Feb; 20(2):137-146. PubMed ID: 30461149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Analysis of HIV-1 genetic subtype and pretreatment drug resistance among men who have sex with men infected with HIV-1 from 19 cities of 6 provinces in China].
    Zhang R; Dong TL; Liang WL; Cao ZB; Xie Z; Liu KM; Yu F; Fu GF; Zhang YQ; Wang GY; Ma QQ; Wu SB; Li Y; Dong W; Jiang Z; Xu J; Wu ZY; Yao J; Pan PL; Qiu MF
    Zhonghua Liu Xing Bing Xue Za Zhi; 2022 Apr; 43(4):523-527. PubMed ID: 35443307
    [No Abstract]   [Full Text] [Related]  

  • 17. The genotype distribution, infection stage and drug resistance mutation profile of human immunodeficiency virus-1 among the infected blood donors from five Chinese blood centers, 2014-2017.
    Liang S; Liu Z; Wang S; Liu J; Shi L; Mao W; Liu C; Wan J; Zhu L; Huang M; Liu Y; Wang J; Ness P; Shan H; Zeng P; He M
    PLoS One; 2020; 15(12):e0243650. PubMed ID: 33347449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A New Mechanism of Resistance of Human Immunodeficiency Virus Type 2 to Integrase Inhibitors: A 5-Amino-Acid Insertion in the Integrase C-Terminal Domain.
    Le Hingrat Q; Collin G; Lê M; Peytavin G; Visseaux B; Bertine M; Tubiana R; Karmochkine M; Valin N; Collin F; Lemaignen A; Bernard L; Damond F; Matheron S; Descamps D; Charpentier C;
    Clin Infect Dis; 2019 Aug; 69(4):657-667. PubMed ID: 30383215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrase strand transfer inhibitor (INSTI)-resistance mutations for the surveillance of transmitted HIV-1 drug resistance.
    Tzou PL; Rhee SY; Descamps D; Clutter DS; Hare B; Mor O; Grude M; Parkin N; Jordan MR; Bertagnolio S; Schapiro JM; Harrigan PR; Geretti AM; Marcelin AG; Shafer RW;
    J Antimicrob Chemother; 2020 Jan; 75(1):170-182. PubMed ID: 31617907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ex-vivo antiretroviral potency of newer integrase strand transfer inhibitors cabotegravir and bictegravir in HIV type 1 non-B subtypes.
    Neogi U; Singh K; Aralaguppe SG; Rogers LC; Njenda DT; Sarafianos SG; Hejdeman B; Sönnerborg A
    AIDS; 2018 Feb; 32(4):469-476. PubMed ID: 29239896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.